ScholarIQanswers from OpenAlex & ORCID
Jean-Marc Ferrero
ResearcherPublications, citations & collaboration network
Jean-Marc Ferrero is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jean-Marc Ferrero have?
ScholarIQindexed works
Jean-Marc Ferrero has 398 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jean-Marc Ferrero have?
ScholarIQcitation count
Jean-Marc Ferrero has 18,640 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jean-Marc Ferrero?
ScholarIQh-index
Jean-Marc Ferrero has an h-index of 60 in OpenAlex.
What is the i10-index of Jean-Marc Ferrero?
ScholarIQi10-index
Jean-Marc Ferrero has an i10-index of 157 in OpenAlex.
What is the ORCID of Jean-Marc Ferrero?
ScholarIQorcid
The ORCID for Jean-Marc Ferrero is on the source record.
What is the OpenAlex record for Jean-Marc Ferrero?
ScholarIQopenalex
The OpenAlex for Jean-Marc Ferrero is on the source record.
What are the most-cited papers on Jean-Marc Ferrero?
ScholarIQmost cited works
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Sandra M. Swain, David Miles, Sung‐Bae Kim, Young‐Hyuck Im, Seock‐Ah Im, Semiglazov Vf, Eva Ciruelos, Andreas Schneeweiß, Sherene Loi, Estefanía Monturus, Emma Clark, Adam Knott, Eleonora Restuccia, Mark Benyunes, Javier Cortés, Richy Agajanian, Rizvana Ahmad, Bahriye Aktas, Victor Hugo Medeiros Alencar, Dino Amadori, Jurandyr Moreira de Andrade, Fábio Franke, Catia Angiolini, Kenjiro Aogi, Jess F. Armor, Wichit Arpornwirat, L. Assersohn, William Audeh, Walter E. Aulitzky, Sérgio Jobim Azevedo, Maria Alejandra Bartoli, Norberto Batista López, María Inés Bianconi, Laura Biganzoli, Ruemu Birhiray, Marianna Bitiņa, Ron Blachy, Kimberly Blackwell, Rita A. Blanchard, Paulette Blanchet, Ion Boiangiu, B. Bower, Christine Brezden‐Masley, Adam Brufsky, Leanne S. Budde, Priscilla B. Caguioa, Lourdes Calvo, Mario Campone, Robert R. Carroll, Hugo R. Castro, Valorie F. Chan, Veena Charu, Saverio Cinieri, Michael Clemens, Emilio Alba Conejo, Eduardo Côrtes, Bruno Coudert, Eduardo Cronemberger, Daniel de Iracema Gomes Cubero, Shaker R. Dakhil, Brooke Daniel, Neville Davidson, Maria de Fátima Dias Gauí, Susana de la Cruz, María del Pilar, G. Delgado, John Ellerton, César Estuardo, Louis Fehrenbacher, Jean-Marc Ferrero, Patrick J. Flynn, Małgorzata Foszczyńska‐Kłoda, Sandra Franco, Hirofumi Fujii, Chris Gallagher, Teresa Gamucci, N Giacomi, Miguel Gil Gil, Antonio González-Martı́n, Vera Gorbunova, E. Gotovkin, Nathan Green, Elza Grincuka, Eva‐Maria Grischke, Vincent Hansen, Jeffrey B. Hargis, Maik Hauschild, Roberto Hegg, Carolyn B. Hendricks, Róbert Hermann, Paulo M. Hoff, Jun Horiguchi, Javier Hornedo Muguiro, Stefano Iacobelli, Kenichi Inoue, Gustavo Ismael, Yoshinori Itoh, Dr Hiroji Iwata, D Jendiroba, Rosa Jochim
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan, Duncan Wheatley, Adrian Murray Brunt, Gia Nemsadze, Richard D. Baird, Yeon Hee Park, Peter S Hall, Timothy Perren, Robert C. Stein, László Mangel, Jean-Marc Ferrero, Melissa Phillips, John Conibear, Javier Cortés, Andrew Foxley, Elza C. de Bruin, Robert McEwen, Daniel Stetson, Brian Dougherty, Shah‐Jalal Sarker, Aaron Prendergast, Max McLaughlin-Callan, Matthew Burgess, Cheryl Lawrence, Hayley Cartwright, Kelly Mousa, Nicholas C. Turner
Prognostic factors in 1038 women with metastatic breast cancer
R. Largillier, Jean-Marc Ferrero, J. Doyen, Jérôme Barrière, M. Namer, Véronique Mari, A. Courdi, Jean‐Michel Hannoun‐Lévi, F. Ettore, Isabelle Birtwisle‐Peyrottes, C. Balu–Maestro, Pierre Yves Marcy, I. Raoust, M. Lallement, Emmanuel Chamorey